Close

Retail

IBI is present with a variety of products on the Italian pharmaceutical distribution market, from ethical drugs to over-the-counter drugs and vitamins, in various treatment areas, such as gastroenterology, liver disease, pain and inflammation, and infectivology.
These historical trademarks, which came about from research and development into original products, were recently joined by the Realsil and Realsil100D line of herbal products and vitamin supplement.
More info: www.realsil.it

OTC DRUGS, SOP AND SUPPLEMENTS

  • METEOSIM tablets
  • SIMETICONE IBI
  • EDEVEN C.M. GEL
  • REALSIL
  • REALSIL100D

GASTROENTEROLOGY

IBI has been present in gastroenterology since the 1970s with products for therapies correlated to stomach diseases, dyspepsia, liver diseases such as gallstones, cholelithiasis, cholestasis and other chronic liver diseases such fatty liver and steatohepatitis, as well as cures for gastrointestinal symptoms with products to improve intestinal symptoms, bloating and constipation.

ANTIBIOTIC TREATMENT

The traditional core business of the Istituto Biochimico Italiano is the production of pharmacologically active raw materials and ethical specialities, in particular in the field of antibiotic treatment. IBI is specialized in the production of injectable sterile penicillin, which is exported all over the world.

INFLAMMATION AND PAIN

In the treatment of pain symptoms and inflammation, IBI proposes a product based on ketoprofen, widely tested for efficacy and speed of action, offering a wide range of oral, injectable and topical formulations for doctors and patients’ requirements. Furthermore, in conditions of capillary fragility associated with oedema and minor traumas, IBI offers a product based on horse chestnut, whose efficacy has been the subject of various clinical trials in the last 30 years, especially in post-surgical oedema and post-traumatic oedema.

Search in the product catalogue

AMPICILLINA E SULBACTAM IBI

Pharmacotherapeutic group: Antibacterial for systemic use - ATC code: J01CR01

Antibiotics
Ampicillin and Sulbactam
BICALUTAMIDE IBIGEN

Pharmacotherapeutic group: Antiandrogens - ATC code: L02BB03

Antineoplastics
Bicalutamide
EDEVEN C.M. GEL

Pharmacotherapeutic group: Drugs for topical use, for joint and muscular pain - ATC code: M02AC

Inflammation/Oedema
Aescin and Diethylamine Salicylate
EDEVEXIN

Pharmacotherapeutic group: Vasoprotectors - capillaroprotective substances - ATC code: C05CX

Inflammation/Oedema
Aescin
IBIFEN

Pharmacotherapeutic group: non-steroidal anti-inflammatory/antirheumatic drugs - ATC code: M01AE03Pharmacotherapeutic group: non-steroidal anti-inflammatory for topical use - ATC code: M02AA10

Inflammation/Oedema
Ketoprofen
IBITAZINA

Pharmacotherapeutic group: Antibacterials for systemic use. Association of penicillins and beta-lactamase inhibitors - ATC code: J01CR05

Antibiotics
Piperacillin and Tazobactam
IBITRED

Pharmacotherapeutic group: Vitamin D and analogues - ATC code: A11CC05

Vitamins
Cholecalciferol Vitamin D3
IBIXACIN

Pharmacotherapeutic group: Fluoroquinolones - ATC code: J01MA02

Antibiotics
Ciprofloxacin
LAXIDO

Pharmacotherapeutic group: Osmotic laxatives - ATC code: A06AD65

Gastroenterology
Macrogol 3350+Sodium Chloride+Sodium Hydrogen Carbonate+Potassium Chloride
METEOSIM

Pharmacotherapeutic group: Other drugs for functional bowel disorders - ATC code: A03AX13

Gastroenterology
Simethicone
PIPERITAL

Pharmacotherapeutic group: Antibacterials for systemic use - ATC code: J01CA12

Antibiotics
Piperacillin
REALSIL 100D

Food supplement of Milk Thistle Silybin complexed with phospholipids with added vitamins D+E

Gastroenterology
Milk Thistle Extract with Phospholipids and Vitamin D+E
REALSIL ORO

Vitamin E food supplement with Milk Thistle (Silybin complexed with phospholipids)

Gastroenterology
Milk Thistle Extract with Phospholipids and Vitamin E
REALSIL

Vitamin E food supplement with Milk Thistle (Silybin complexed with phospholipids)

Gastroenterology
Milk Thistle Extract with Phospholipids and Vitamin E
SIMETICONE IBI

Pharmacotherapeutic group: Other drugs for functional bowel disorders - ATC code: A03AX13

Gastroenterology
Simethicone
TEICOPLANINA IBIGEN

Pharmacotherapeutic group: Glycopeptides Antibacterials - ATC code: J01XA02

Glycopeptide antibacterials
Teicoplanin
TOBRAMICINA IBI

Pharmacotherapeutic group: Antibacterials for systemic use - ATC code: J01GB01

Antibiotics
Tobramycin
URSILON

Pharmacotherapeutic group: Preparations based on bile acids - ATC code: A05AA02

Gastroenterology
Ursodeoxycholic Acid

Thank you

We sent you an email. To activate the newsletter click on the link you will find in the message, thank you!

CHIUDI

Private area

Sign up
Do not remember your password?
Cancel Log in

Log in to restricted area

Cancel Log in

Registration

Notice on the treatment of personal data

Dear visitor, in the following sections we will describe how the reserved area of the www.ibi-lorenzini.it website is managed as far as processing personal data of users. The notice is issued pursuant to art. 13 of EU Regulation 679/2016 (hereinafter also the Regulation) on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and applies to those who interact with the website of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (hereinafter I.B.I.), which can be accessed at the following address: www.ibi-lorenzini.it, the opening page of the official I.B.I. website. The notice only applies to the I.B.I. website. It does not apply to any other websites that the user may access through links.

  1. The processing of the personal data that you supply, which are also used for the creation of your user profile, and which will be included in the “Doctors’ Details” database, has the following purposes:

  • carry out medical sales related activities for drugs for human consumption. Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. and Ibigen S.r.l., part of the same company group (hereinafter also Ibigen Group), carry out such activities in compliance with the provisions of the current regulations, with particular, but not exclusive, attention to Italian Legislative Decree no. 219 of 24.04.2006 and subsequent modifications. In view of the objectives of the Ibigen Group, it is important to point out that the processing activities do not deal with any special data. The supply of the data for the medical sales activities is necessary, and failure to provide consent will make it impossible for us to fulfil the above objectives;

  • forwarding of invitations or information on congresses, conferences, seminars, communications on initiatives promoted or sponsored by the Ibigen group, regular or occasional publications, information on new products, methods and services. Such activities are carried out by e-mail, fax, SMS, normal post or telephone. The supply of the data for such purposes is optional, and failure to supply them will result in the information not being forwarded.

  1. As far as the creation of your profile on our website, we remind you that your password is strictly confidential and should not be disclosed.
  2. Your data will not be disclosed, but may be shared with individuals, companies, associations or professional studios providing support or consultancy services to the Ibigen Group, the medical sales representative network, our suppliers and any sub-suppliers - from time to time entrusted with activities connected with the above objectives -, mailing or statistical survey companies, or companies for the forwarding of scientific documentation, and individuals authorised to access the data by law and/or pursuant to secondary regulations.
  3. Such people may only acquire knowledge of your personal data for the above mentioned purposes.
  4. The Owners of the Treatment (Data Controllers) are the two companies of the Ibigen Group with legal headquarters at Via Fossignano no. 2, Aprilia (LT), Italy.
  5. Personal data are processed using manual and automated means, for the time necessary for reaching the objectives for which they were collected. Special safety measures are in place to avoid data loss, unlawful or incorrect use and unauthorised access.
  6. Lastly, we also inform you that you can at any time exercise the rights contemplated by the Regulation, and in particular request access to the data, their correction, update and block, or you can withdraw your consent, or request the limitation of the processing or the cancellation of the data. As data subject, you also have the right to issue a complaint with the relevant control Authority. Such rights may be exercised in writing to the following e-mail address: info@ibi-lorenzini.com.
  7. The Data Protection Officer may be contacted at the following e-mail address: dpo_ibi@protectiontrade.it

* Required fields

Cancel